Article Listing - Gilead's Hepsera performs well in long-term hep B trial

HUNGARY'S EGIS SEEKS STRATEGIC PARTNERSHIP

6 April 1992

Egis Pharmaceuticals is the latest Hungarian drugmaker to seek a strategic partnership as part of the on going privatization of...

HUNGARY'S EGIS SEEKS STRATEGIC PARTNERSHIP

6 April 1992

Egis Pharmaceuticals is the latest Hungarian drugmaker to seek a strategic partnership as part of the on going privatization of...

AMA REPORT ON CONTRACEPTIVES

6 April 1992

The outcome of a report from the American Medical Association's Board of Trustees concludes that long-acting contraceptives may be medically...

US PHARMACY COMPOUNDING GUIDE

6 April 1992

The US Food and Drug Administration has, for the first time, issued a pharmacist compounding compliance guide, due to the...

BAYER DIAGNOSTICS' NEW INSTRUMENT

6 April 1992

Bayer Diagnostics has launched the Ames Clinitek 200+, benchtop, semi-automated urine chemistry analyser for moderate to large volume urine testing....

DURAMED'S ISONIAZID

6 April 1992

The resurgence of tuberculosis brought about by the AIDS epidemic has caused generic drugs company Duramed Pharmaceut-icals to resume manufacture...

MILES STAFF CUTS

6 April 1992

Miles Inc of the USA is to reduce its workforce at its Diagnostics Business Group by 600, around 9%. The...

ARES-SERONO GAINS RIGHTS TO CUROSURF

6 April 1992

Swiss pharmaceutical group Ares-Serono has acquired exclusive marketing rights in most European territories for a natural pulmonary surfactant product, Curosurf,...

STOCK MARKET COMMENTARY: NEW YORK

6 April 1992

NEW YORK: share prices moved up and down during the reporting week, first with lower car sales pushing the Dow...

ICH STEERING COMMITTEE MEETING

6 April 1992

The Steering Committee for the Second International Conference on Harmonization (ICH) of technical requirements for the registration of pharmaceutical products...

Showing 94691-94700 of 95572 articles